Navigation Links
ZFP in Medical News

Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009

Analysis of Subjects with Moderately Severe Diabetic Neuropathy Shows Statistically Significant Improvement in Multiple Quantitative Neurological Endpoints RICHMOND, Calif., June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of as y...

Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference

...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...

Sangamo BioSciences Reports First Quarter 2009 Financial Results

...n in Nature of the successful application of zfp technology for the efficient generation of maize p...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...

Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives

...ve had together to confirm our conviction that the zfp platform has the ability to truly transform the fi... Mr. Peribere. "We have established that Sangamo's zfp technology can be used to regulate and modify gene... clinical data from our Phase 1b trial of our lead zfp Therapeutic(TM), SB-509, an activator of vascular ...

Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference

...ill provide an update on the progress of Sangamo's zfp Therapeutic development programs and an overview o...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...

New Gene Therapy Treats Diabetic Neuropathy

...Faculty of Life Sciences. ‘Our approach to gene therapy is quite different to previous attempts at treatment: we use a DNA-binding protein called zfp TFTM to poke life into the patient's own genes and produce a growth factor that has a role in nerve protection and regeneration. ‘As the data in ...
ZFP in Medical Technology

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

Presentation Details Statistically Significant and Clinically Relevant Results for SB-509 in Development for Treatment of Diabetic Neuropathy SAN FRANCISCO, June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of encouraging Phase 1b ...

Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting

ZFN Modified Cells Show Glioblastoma Killing in the Presence of Dexamethasone in Mouse Tumor Model SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced the presentation of positive data in a mouse tumor model from its ZF...

Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy

Milestone Triggers Payment to Sangamo from JDRF RICHMOND, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that the company has completed enrollment of its randomized, double-blind, repeat-dosing, placebo-controlled, multi-center P...

Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting

Statistically Significant Improvements in Function in Spinal Cord Injury Model With ZFP TF Treatment RICHMOND, Calif., May 03, 2007 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the presentation of preclinical data from its ZFP Therapeutic(TM) program in nerve regeneration at...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...

Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech

...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. The most advanced zfp Therapeutic(TM) development program is currently i...

Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences

...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...

Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives

... in laboratories worldwide and we expect Sangamo's zfp technology to be nothing short of revolutionary fo...past year has been a year of real progress for our zfp technology platform," said Edward Lanphier, presid...us to make significant progress in moving our lead zfp Therapeutic into multiple Phase 2 clinical trials ...

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)

...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...

Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells

...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...
ZFP in Biological News

Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection

Sangamo BioSciences, Inc. today announced that data from its program to develop a ZFP Therapeutic for HIV/AIDS were presented at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC. The study represents the first demonstration that cells can b...

Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference

...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TFTM) that can control ...

Trial success for diabetic nerve therapy

...s Faculty of Life Sciences. "Our approach to gene therapy is quite different to previous attempts at treatment: we use a DNA-binding protein called zfp TFTM to poke life into the patient's own genes and produce a growth factor that has a role in nerve protection and regeneration. "As the data in th...
ZFP in Biological Technology

Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting

Progenitor Cell Mobilization Observed in Subjects with Critical Limb Ischemia Treated with ZFP Therapeutic MIAMI, May 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of data from a Phase 1 clinical trial of a zinc finge...

Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals

RICHMOND, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it had entered into a License Agreement with Open Monoclonal Technologies (OMT), a private company based in Palo Alto, California. Under this agreement, Sangamo will provid...

Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production

Companies Agree to Expanded Access to ZFN Technology To Potentially Improve Protein Production RICHMOND, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it has entered into a second Research and License Agreement...

Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting

Statistically Significant Improvements in Function and Tissue Preservation with ZFP TF Treatment in Spinal Cord Injury Model SAN DIEGO, Nov. 7 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of preclinical data from its ZFP Therape...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

...hlights Presentation of positive Phase 2 zfp Therapeutic data at ADA 2009. Sangamo announced t...unreleased positive Phase 2 clinical data from its zfp Therapeutic(TM) program to develop SB-509 as a tre...angamo demonstrating the successful application of zfp technology for the efficient generation of maize p...

Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast

...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. The most advanced zfp Therapeutic(TM) development program is currently i...

Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference

...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...

Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research

...valuate the safety and tolerability of SB-728-T, a zfp Therapeutic based on Sangamo's CCR5-disrupting ZFN...our efforts to develop the next generation of this zfp Therapeutic, an in-vivo formulation for direct i...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...

Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species

...Sangamo demonstrated the successful application of zfp technology for the efficient generation of maize p... , scientists at Dow AgroSciences and Sangamo used zfp Nucleases (ZFNs(TM)) to introduce a herbicide tole...ul demonstration of the broad applicability of our zfp technology platform," stated Philip Gregory, D. Ph...

Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast

...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...
Other Tags
(Date:8/23/2014)... 23, 2014 On Monday, August 18th, ... data breach suffered by Community Health Systems, which ... of 4.5 million records containing Personally Identifiable Information (PII) ... to Mandiant, who was engaged to investigate the incident, ... advanced group of cyber attackers based in China, who ...
(Date:8/23/2014)... GA (PRWEB) August 23, 2014 Young adults in ... or doing drugs should pick up the phone and call the ... troubled teen drug addict . , Troubled Teen Athens is ... is ready to finally take the necessary steps to end substance ... they are quick to go to friends or peers when really ...
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
(Date:8/22/2014)... Recently, Skmen.com, an experienced supplier of fashionable ... dresses in its online store. Moreover, all these excellent ... 28% off. All the international clients can obtain these ... , The company’s professional online workers update its ... customers more the latest information about its new arrivals ...
(Date:8/22/2014)... Recently, UWDress.com, a leading online supplier of wedding ... range of empire bridesmaid dresses to its product ... summer promotion for these high quality items. All of them ... 75 percent off. , The company’s new items can ... assistance on its website. It is true that all its ...
Breaking Medicine News(10 mins):Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
(Date:8/21/2014)... In a finding that has implications for life in ... in the solar system, LSU Associate Professor of Biological ... National Science Foundation, or NSF, this week published a ... lake that lies 800 meters (2600 feet) beneath the ... microbial ecosystems.", Given that more than 400 subglacial lakes ...
(Date:8/21/2014)... connectors, designed by an international standards process, will be ... to an invited review published in the OnlineFirst version ... ), the official journal of the American Society for ... greatly reduce the occurrence of misconnection that can be ... which are used to join medical devices, components, and ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4New feeding tube connectors will improve patient safety 2
Other Contents